Sapanisertib (MLN0128) - mTOR inhibitor CAS:1224844-38-5
- HHD
- Wuhan
- 100 piece/month
New arrival!
Good quality!
IN STOCK
Product Name | Sapanisertib (MLN0128) |
CAS No. | 1224844-38-5 |
Appearance | Powder |
Purity | 99% |
MF | C15H15N7O |
Shelf Life | 2 Years |
| Grade | Enterprise standard |
| Solubility | Soluble in DMSO (up to 25 mg/ml) |
| Usage | For research use only |
Sapanisertib (MLN0128, INK128, TAK-228), a dual mTORC1/2 kinase inhibitor, is undergoing further clinical trials after showing a suitable safety profile and preliminary antitumor activity in combination with paclitaxel, with and without trastuzumab, in a range of advanced solid tumor types
![ADQ//3-Acetyl-5,8-dichloro-2-[(2,4-dichlorophenyl)amino]-4(1H)-quinolinone CAS:1151813-62-5](https://img.waimaoniu.net/1363/1363-202212061656158414.jpg)
Product Tag:
